Last week, a brand founder called me in a panic. She'd invested $40,000 into gummy development, only to discover her hero ingredient, a clinical-dose botanical extract, would require customers to chew eight gummies daily. Her focus groups laughed at her.
This happens more often than you'd think. Brands get seduced by the "gummy boom" without understanding what's happening behind the manufacturing curtain. After two decades formulating both formats, I can tell you the gummy versus capsule decision comes down to physics, economics, and strategy, not consumer preference.
The Minimum Order Reality That Changes Everything
Those "gummy trends" articles never mention that gummy manufacturing forces you into a different business model from day one.
With capsules, you can start small. We're talking 5,000 to 12,000 units for initial production runs. You can test the market, gather feedback, tweak your formula, and move on. The machinery switches between formulations quickly. Your capital isn't locked up in massive inventory positions before you've proven demand.
Gummies are a different universe entirely.
Most gummy manufacturers won't even turn on the cookers for less than 30,000 units. Many require 50,000 to 100,000+ for custom formulations. Why? The production process involves cooking massive batches, precise temperature control during cooling, careful demolding, drying time, coating application, and extensive quality checks. You can't just whip up a small test batch on existing equipment.
I've watched brands commit to $60,000 in inventory before they've made their first sale. That's math, not a criticism of gummies. But it means you'd better be damn sure about your formulation, your market, and your ability to move product before you commit.
The Moisture Problem Nobody Wants to Discuss
Pop open a gummy vitamin. Feel that slight tackiness? That's 10-20% water content, and it's your stability nightmare.
Water is the universal solvent. It accelerates almost every degradation pathway we worry about in supplement formulation. Probiotics? Many strains hate moisture. Certain B vitamins? They start breaking down. Botanical extracts with sensitive compounds? The degradation clock is ticking faster.
I've seen stability studies where gummy formulations lost 30-40% potency in real-world distribution conditions. I mean sitting in a non-climate-controlled warehouse in Arizona during summer, not a controlled stability chamber. The supplement facts panel says 100% of label claim. The actual product falls far short. Manufacturers respond with overages: they dose in extra active ingredient to cover the expected loss so the label claim still holds at the end of shelf life. That extra active is real money, and it is money spent on chemistry you know will degrade before the customer sees it.
Capsules operate in a completely different stability universe. A well-formulated capsule with proper desiccant protection keeps moisture away from your ingredients. We're talking <5% relative humidity inside that bottle if you do it right.
The Compartmentalization Advantage
Capsules let you segregate incompatible ingredients within a single dose, and this is where the format earns its keep.
Take a multi-ingredient immune support product: vitamin C (acidic), probiotics (pH-sensitive), and zinc (potential interaction issues). In a gummy, all three sit together in that moist environment. Every chemical interaction that could possibly go wrong is happening, continuously, from the moment of manufacture.
In a two-piece capsule, we can get creative:
- Enteric-coated probiotic beads that don't release until they hit the intestines
- Buffered vitamin C in one granulation to control pH
- Chelated zinc in a separate particle size to minimize interaction
- All of it delivered in one swallow
That approach extends shelf life by 12-18 months while delivering what your label promises. I've reformulated dozens of failed gummy products into stable capsule formulations using exactly this approach.
The Dose Density Deception
The dose math is what makes marketing teams cry.
A standard gummy weighs 2-3 grams. Sounds like plenty of room for ingredients, right? Except you need to account for the gummy base itself:
- Glucose syrup or sugar: 40-60% of the gummy
- Gelatin or pectin: 8-12%
- Water content: 10-20%
- Flavoring, coloring, coating, citric acid: 5-10%
After all that infrastructure, you've got maybe 15-25% left for actual active ingredients. On a 3-gram gummy, that's 450-750mg of space for everything you want to deliver.
Now compare that to a size 00 capsule, the industry standard. It holds 735mg of powder. The critical difference is that the powder can be 90-95% active ingredients. You're delivering 660-700mg of actives in a single capsule versus maybe 300-400mg in a 2-gummy serving.
When does this gap become a deal-breaker?
The Clinical Dose Problem
Take a magnesium supplement at 400mg elemental magnesium, a dose backed by research. Using magnesium glycinate (a premium, well-absorbed form), you need roughly two to three grams of the compound to deliver 400mg elemental magnesium.
In capsules, that's three size 00 capsules. Totally manageable.
In gummies, you're looking at 6-8 gummies depending on your base formulation. Maybe more if you need room for flavoring to mask magnesium's naturally bitter taste. I've yet to meet a consumer excited about chewing eight gummies daily.
So brands compromise. They switch to magnesium citrate (cheaper, less bioavailable, but better taste profile). They reduce the dose to 200mg. They add more sugar to improve palatability. Before you know it, you're making the product the format allows, not the one you set out to create.
The Regulatory Crossover Most Brands Miss
Both formats fall under FDA dietary supplement regulations and cGMP requirements. But gummies introduce complications that capsule manufacturers never touch.
Gummies need colors and flavors. Seems simple until you dig into the regulatory implications:
- Natural colors: Require agricultural supply chain verification, have limited stability, and often fade within 6-12 months on shelf
- Natural flavors: Often contain carrier systems with tree nuts, soy, or gluten, which means allergen declarations
- Synthetic colors: Stable and consistent, but try explaining FD&C Yellow No. 5 to a clean-label-focused consumer base
Then there's the confection classification issue. A few states treat candy-like supplement formats with extra scrutiny, which can add state-level labeling questions and facility requirements beyond standard FDA oversight. It's not universal, but it's state-specific compliance work that adds complexity and cost.
Capsules bypass all of this: no colors, minimal flavoring needs, straightforward supplement classification. Your regulatory burden is lighter.
Texture: The Spec Nobody Thinks About
Consumer expectation for gummies is brutal: they need to taste good, chew easily, not stick to teeth, not stick to each other in the bottle, and maintain all these properties for 18-24 months.
We measure this with actual specifications:
- Hardness: Typically 800-1,200 grams-force using texture analyzer equipment
- Cohesiveness: How well the gummy holds together under compression
- Springiness: Recovery characteristics after the initial bite
Every ingredient choice impacts texture. Add a hygroscopic mineral? Your gummy will pull moisture over time and get softer. Increase your antioxidant level? It might interfere with gelation chemistry. Switch pectin suppliers to reduce cost? Completely different texture profile that requires reformulation.
Achieving stable texture across a full shelf life demands 6-9 months of stability testing, including accelerated and real-time studies. You're testing at different temperatures, different humidity levels, simulating distribution conditions. The investment is substantial before you can guarantee consistency.
Capsule texture specification: can the consumer swallow it? That's it. The bar is far lower.
The Sugar-Free and Pectin Complication
These problems get harder when the brief calls for sugar-free or vegan. In a conventional gummy, sugar and gelatin do a lot of the structural work. Sugar holds water and fills out the body; gelatin sets the gel.
Pectin sets by a different mechanism than gelatin and is more sensitive to pH, dissolved solids, and calcium balance. Sugar-free systems built on polyols or stevia blends change the bulk and water-holding behavior that sucrose provides. Both directions raise the difficulty of hitting a stable texture, which is why sugar-free and pectin products often need more stability testing, not less.
None of this makes those formats bad. It does mean a brief calling for pectin, sugar-free, or natural color puts you on the harder end of gummy manufacturing, and that work is what separates a manufacturer who has run it repeatedly from one learning on your batch.
What Your Format Choice Actually Signals
After working with hundreds of brands, I've noticed a pattern. Your format choice broadcasts your go-to-market strategy whether you realize it or not.
Gummies Telegraph:
- Mass market retail ambitions (visual shelf appeal matters)
- Broad demographic targeting, including supplement-skeptical consumers
- Willingness to invest heavily in marketing (you need to move those larger MOQs)
- Brand positioning focused on experience and convenience over clinical precision
Capsules Telegraph:
- Performance and efficacy as primary values
- Targeting educated consumers who understand dosing matters
- Content marketing and education-driven customer acquisition
- Product development agility and willingness to iterate based on feedback
Neither approach is superior. They're different strategic positions serving different markets. The brands that struggle are those trying to force a format to serve the wrong strategy.
You can't build a research-backed, clinically-dosed brand in gummy format without real compromises. You also can't successfully launch capsules into mass retail without strong educational content, because you're competing on shelf appeal in an arena where gummies dominate.
The Portfolio Play (For Sophisticated Brands)
The smartest brands I work with don't choose between formats. They deploy both strategically within their product portfolio.
The model that works:
- Flagship clinical formulations in capsules: Complete clinical doses, complex multi-ingredient protocols, serious efficacy positioning
- Entry-level or compliance-focused products in gummies: Single-nutrient formulas, children's products, bedtime supplements where the ritual experience adds value
This approach creates natural benefits:
- Maximum consumer accessibility across different sophistication levels
- Built-in upsell pathways (gummy customers graduate to comprehensive capsule protocols)
- Optimized manufacturing economics (variety in capsules, volume in gummies)
One of our clients launched a sleep gummy as their entry product: melatonin, L-theanine, simple formulation. They use it to capture supplement newcomers and Amazon impulse buyers. Then they upsell to their comprehensive sleep capsule protocol with 8 ingredients at clinical doses. The gummy builds the list. The capsules build the business.
Questions That Separate Real Manufacturers From Pretenders
When you're evaluating contract manufacturers, these questions reveal who actually understands format-specific challenges:
For Gummy Manufacturers:
- "Walk me through your water activity testing protocol. At what intervals do you test, and what's your action threshold?"
- "Show me stability data on temperature excursion recovery. What happens if product sits in a 100°F warehouse for two weeks?"
- "How do you validate natural color stability across different batch sizes?"
- "What's your reformulation process when a new ingredient affects your gelation chemistry?"
For Capsule Manufacturers:
- "What segregation strategies do you employ for hygroscopic ingredients?"
- "How do you validate uniform distribution in blending when one ingredient represents less than 0.5% of the formula?"
- "Walk me through your enteric coating process validation."
- "How do you manage moisture ingress for products requiring less than 3% moisture specifications?"
Manufacturers with specific, technical answers understand the nuances. Those offering vague, marketing-speak responses are revealing surface-level expertise. You'll pay for that gap later when reformulations eat your margins.
Making the Right Choice for Your Brand
Format selection is a strategic alignment decision that ripples through every aspect of your business, not a popularity contest.
Choose Gummies When:
- You have proven demand justifying 30,000+ unit minimum orders
- Your formulation works within dose density limitations (single nutrients, lower doses)
- Your brand strategy emphasizes experience, taste, and accessibility over clinical positioning
- You can absorb 6-9 month stability testing timelines before launch
- You have the capital to manage larger inventory positions
Choose Capsules When:
- You need formulation flexibility and lower inventory risk for market testing
- Ingredient doses matter for clinical credibility and efficacy claims
- Your ingredients are moisture-sensitive, oxygen-sensitive, or incompatible in aqueous environments
- You want to test and iterate multiple formulations based on customer feedback
- Your go-to-market strategy relies on education and content rather than impulse purchase
Choose Both When:
- You understand each format serves different strategic purposes within your portfolio
- You have the operational infrastructure to manage multiple SKU complexities
- You're building for long-term market positioning across different consumer segments
- You can use one format as an acquisition tool and the other as a retention/upsell mechanism
The Bottom Line
At KorNutra, we never start a format conversation by asking what's trending. We start by understanding your three-year business strategy, your target customer's sophistication level, your capital position, and your risk tolerance.
Because the format decision you make today determines your manufacturing costs, inventory risk, formulation possibilities, regulatory burden, and market positioning for years to come. It's foundational architecture, not a detail.
Get it right, and your format becomes a competitive advantage that reinforces everything else you're building. Get it wrong, and you're reformulating in 18 months, explaining to investors why you need another $50,000 to fix what should have been right from the start.
I've seen both scenarios play out dozens of times. The difference is understanding that gummies and capsules are more than delivery mechanisms. They're strategic choices that reveal whether you understand the manufacturing reality behind the marketing promise.
That founder I mentioned at the beginning? We reformulated her product in capsules. Two capsules daily instead of eight gummies. She launched three months later instead of going back for another round of gummy reformulation. Last I heard, she's doing seven figures annually.
Format matters. But strategic clarity matters more.